3:22
- ABC News
- November 19, 2020
Pfizer vaccine 95% effective in final analysis, company seeks final safety step
Pfizer and partner BioNTech said Wednesday the company will apply for FDA emergency authorization “within days,” following the promising final analysis of the Phase 3 trial.